G 229 (Lamotrigine (chewable, dispersible) 25 mg)
Pill imprint G 229 has been identified as Lamotrigine (chewable, dispersible) 25 mg.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; restless legs syndrome; post traumatic stress disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for G 229 (Lamotrigine (chewable, dispersible) 25 mg)
- Imprint:
-
G
229 - Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0229
- Inactive Ingredients:
- aspartame
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
povidone k25
More resources
Lamotrigine (chewable, dispersible) is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
